| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.2 | 4e-05 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.0009 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.001 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.001 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |